학술논문
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
Document Type
Article
Author
Besse, B.; Pons-Tostivint, E.; Park, K.; Hartl, S.; Forde, P.M.; Hochmair, M.J.; Awad, M.M.; Thomas, M.; Goss, G.; Wheatley-Price, P.; Shepherd, F.A.; Florescu, M.; Cheema, P.; Chu, Q.S.C.; Kim, S.-W.; Morgensztern, D.; Johnson, M.L.; Cousin, S.; Kim, D.-W.; Moskovitz, M.T.; Vicente, D.; Aronson, B.; Hobson, R.; Ambrose, H.J.; Khosla, S.; Reddy, A.; Russell, D.L.; Barrett, J.C.; Iyer, S.; Keddar, M.R.; Conway, J.P.; Dean, E.; Jewsbury, P.J.; Barry, S.T.; Cosaert, J.; Kumar, R.; Dressman, M.; Heymach, J.V.
Source
In: Nature Medicine . (Nature Medicine, March 2024, 30(3):716-729)
Subject
Language
English
ISSN
1546170X
10788956
10788956